Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.70 |
| ▸ | NPC1 | O15118 | 6/20 | 0.70 |
| ▸ | RAB9A | P51151 | 5/20 | 0.70 |
| ▸ | TP53 | P04637 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | HTT | P42858 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.70 |
| ▸ | CCR1 | P32246 | 3/20 | 0.67 |
| ▸ | CCR5 | P51681 | 3/20 | 0.67 |
| ▸ | CCR8 | P51685 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | METAP1 | P53582 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31609343 | 1.00 | KDM4E (0.70) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| Hydrogen Sulfide SCHEMBL3749800 | 0.98 | KDM4E (0.67) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| Water SCHEMBL3749603 | 0.98 | KDM4E (0.67) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL1993381 | 0.88 | KDM4E (0.52) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL29696261 | 0.88 | KDM4E (0.52) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| Dipyridyl SCHEMBL4909534 | 0.85 | KDM4E (0.82) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL30792004 | 0.84 | GOT1 (0.46) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL1456807 | 0.84 | GOT1 (0.46) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL29442588 | 0.84 | GOT1 (0.46) | KDM4ENPC1RAB9ATP53SMN1; SMN2 | |
| SCHEMBL1456153 | 0.82 | KDM4E (1.00) | KDM4ENPC1RAB9ATP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143074-A | 3-benzyloxy-6-pyridylpyridazine compound as well as preparation method and application thereof | 四川大学 | 2023-12-01 | — | — | CN | claimed |
| CN-115458749-A | Composite negative current collector and preparation method thereof | 扬州纳力新材料科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-115312971-A | Polymer film, preparation method thereof and composite current collector | 江阴纳力新材料科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| EP-2069345-A2 | PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES | Centre National de la Recherche Scientifique (CNRS) (FR) | 2009-06-17 | — | — | EP | claimed |
| US-20090036418-A1 | Pharmaceutical composition for treatment of cancer containing pyridylpyridazine or transition metal complex thereof as active ingredient | INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, THE (KR) | 2009-02-05 | — | — | US | claimed |
| WO-2008012440-A2 | PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2008-01-31 | — | — | WO | claimed |
| WO-2007007943-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OF CANCER COMPRISING PYRIDYLPYRIDAZINE COMPOUNDS OR THEIR TRANSITION METAL COMPLEXES | THE INDUSTRY AND ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) (KR) | 2007-01-18 | — | — | WO | claimed |
| US-4764454-A | Color photographic material with color forming ligand compounds and a method of processing | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-16 | — | — | US | claimed |
| US-20250388587-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN SHANGHAI INC (CN) | 2025-12-25 | — | — | US | disclosed |
| EP-4230708-A1 | LIGHT-EMITTING DEVICE AND USE THEREOF IN DISPLAY | Zhejiang Brilliant Optoelectronic Technology Co., Ltd. (CN) | 2023-08-23 | — | — | EP | disclosed |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | UNIV ARIZONA STATE (US) | 2023-08-10 | — | — | US | disclosed |
| CN-115458749-A | Composite negative current collector and preparation method thereof | 扬州纳力新材料科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115312971-A | Polymer film, preparation method thereof and composite current collector | 江阴纳力新材料科技有限公司 | 2022-11-08 | — | — | CN | disclosed |
| EP-3747915-A1 | USE OF QUATERNISED NITROGEN COMPOUNDS AS GASOLINE ADDITIVES | BASF SE (DE) | 2020-12-09 | — | — | EP | disclosed |
| EP-0186869-A2 | Colorless ligand-releasing monomers and polymers and their use to provide dyes with metal ions | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-07-09 | — | — | EP | disclosed |
| EP-0186870-A2 | Photographic elements and processes utilizing imagewise reduction of ferric ions | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-07-09 | — | — | EP | disclosed |
| US-4568633-A | THEN REACTING WITH COMPLEXING COMPOUND TO FORM DYE | EASTMAN KODAK COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| US-4557998-A | AVOIDS COUPLER SOLVENTS | EASTMAN KODAK COMPANY (US) | 1985-12-10 | — | — | US | disclosed |
| US-4555478-A | Photographic element and process for providing metal complex color images | EASTMAN KODAK COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4555477-A | Photographic element and process utilizing metal complex color masking dyes | EASTMAN KODAK COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388587-A1 | TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE | ERBB2, MUSK, ERBB3 | KDM4E 3350/4885NPC1 3254/4885RAB9A 3385/4885 |
| US-20230255101-A1 | Tetradentate Metal Complexes with Carbon Group Bridging Ligands | STAU1, POLR1G, CLTC | KDM4E 4613/4885NPC1 3632/4885RAB9A 1401/4885 |
| US-20090036418-A1 | Pharmaceutical composition for treatment of cancer containing pyridylpyridazine or transition metal complex thereof as active ingredient | CA5A, PDCD11, PDCD1 | KDM4E 1038/4885NPC1 4803/4885RAB9A 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.